Detalhe da pesquisa
1.
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC).
Prostate Cancer Prostatic Dis
; 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341461